X 
Financials Ratios
Home | Market Info | Company Profile | Financials Ratios
Shilpa Medicare Ltd.
BSE CODE: 530549   |   NSE CODE: SHILPAMED   |   ISIN CODE : INE790G01031   |   22-Nov-2024 Hrs IST
BSE NSE
Rs. 911.00
-24.8 ( -2.65% )
 
Prev Close ( Rs.)
935.80
Open ( Rs.)
945.00
 
High ( Rs.)
954.20
Low ( Rs.)
901.60
 
Volume
28167
Week Avg.Volume
30552
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 912.80
-23.2 ( -2.48% )
 
Prev Close ( Rs.)
936.00
Open ( Rs.)
947.05
 
High ( Rs.)
955.00
Low ( Rs.)
905.00
 
Volume
944628
Week Avg.Volume
703610
 
52 WK High-Low Range(Rs.)
313.15
959.5
Particulars Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operational & Financial Ratios          
   Earnings Per Share (Rs)3.10  -5.70  2.32  7.98  20.63  
   CEPS(Rs)8.82  -0.34  6.33  10.72  24.92  
   DPS(Rs)0.00  0.00  1.10  1.10  1.10  
   Book NAV/Share(Rs)246.85  243.96  237.97  200.89  178.27  
   Tax Rate(%)29.28  15.09  26.66  27.84  20.79  
Margin Ratios          
   Core EBITDA Margin(%)7.12  -22.27  3.09  11.08  29.50  
   EBIT Margin(%)17.87  -15.12  10.24  37.46  26.88  
   Pre Tax Margin(%)12.30  -23.53  7.70  35.09  26.35  
   PAT Margin (%)8.70  -19.98  5.65  25.32  20.87  
   Cash Profit Margin (%)24.71  -1.19  15.40  33.99  25.21  
Performance Ratios          
   ROA(%)1.09  -1.83  0.74  2.87  9.12  
   ROE(%)1.26  -2.37  1.09  4.21  12.30  
   ROCE(%)2.36  -1.61  1.61  4.67  13.13  
   Asset Turnover(x)0.13  0.09  0.13  0.11  0.44  
   Sales/Fixed Asset(x)0.38  0.32  0.43  0.31  1.09  
   Working Capital/Sales(x)2.06  0.63  2.42  0.84  1.47  
Efficiency Ratios          
   Fixed Capital/Sales(x)2.65  3.10  2.30  3.26  0.92  
   Receivable days150.65  158.13  164.12  315.80  92.44  
   Inventory Days121.60  144.60  204.94  358.76  86.71  
   Payable days194.46  139.04  218.12  479.17  104.54  
Valuation Parameters          
   PER(x)148.66  0.00  171.02  41.81  11.85  
   PCE(x)52.31  -678.18  62.71  31.15  9.81  
   Price/Book(x)1.87  0.94  1.67  1.66  1.37  
   Yield(%)0.00  0.00  0.28  0.33  0.45  
   EV/Net Sales(x)13.38  9.18  10.16  12.68  2.91  
   EV/Core EBITDA(x)35.91  92.25  57.96  49.68  9.16  
   EV/EBIT(x)74.88  -60.70  99.22  33.85  10.82  
   EV/CE(x)1.81  0.95  1.60  1.42  1.28  
   M Cap / Sales12.93  8.04  9.66  10.59  2.47  
Growth Ratio          
   Net Sales Growth(%)25.06  -30.61  38.86  -68.11  21.40  
   Core EBITDA Growth(%)368.32  -60.60  -4.68  -74.39  25.52  
   EBIT Growth(%)247.78  -202.49  -62.05  -55.56  22.90  
   PAT Growth(%)154.44  -345.47  -69.03  -61.30  23.90  
   EPS Growth(%)154.44  -345.48  -70.91  -61.30  23.90  
Financial Stability Ratios          
   Total Debt/Equity(x)0.07  0.14  0.09  0.40  0.26  
   Current Ratio(x)1.67  2.62  1.91  1.65  2.52  
   Quick Ratio(x)1.17  2.26  1.36  1.01  1.95  
   Interest Cover(x)3.21  -1.80  4.04  15.85  50.05  
   Total Debt/Mcap(x)0.04  0.14  0.06  0.24  0.19